Cue Health, headquartered in San Diego, received emergency use FDA authorization for two COVID-19 tests early in the pandemic to help people detect if they were infected with the virus.
Health care company Cue Health received emergency use authorization for two COVID-19 tests from the FDA early on in the pandemic to help people detect whether they have been infected with the virus.
PharmaTher received the new date after it “promptly completed the necessary tests and responses” to address the FDA’s concerns ... Veklury was the first COVID treatment to win backing ...
Years after the onset of the pandemic, Arizona's elementary and middle schoolers are still missing class at much higher rates than before COVID-19 hit ... 30% of kids are on track to be ...
With the acute phase of the Covid-19 pandemic fading even as the coronavirus persists and evolves, a new normal is taking shape around the world. The decision came after a scorching hearing in ...
Oct. 2, 2023 — In September 2022, new bivalent COVID-19 boosters became available in the United States, but less than 20% of the eligible population ultimately received one. A new study ...
The concurrent administration of bivalent mRNA COVID-19 boosters and influenza vaccines should be considered as a strategy to potentiate neutralizing antibody responses against SARS-CoV-2.
COVID-19 usually is milder in kids than in adults, though some children have gotten pretty sick from it. Many parents wonder what to do if their child gets sick. Here's what you need to know.
Unlimited access to premium stories for as little as $12.95 /mo.
May 16, 2024 • More than a million people could get health care if these states would pass laws expanding Medicaid. Most residents want the expansion but entrenched politics stands in the way.
The new bivalent vaccine can provide significant protection this winter against COVID-19. The new bivalent vaccine can provide significant protection this winter against COVID-19. 0:46 Health and ...
Pfizer-BioNTech’s COVID-19 booster shots are available for those who received their Pfizer series at least six months ago and are 65 and older and/or residents in a long-term care setting ...